Skip to content

Advertisement

BMC Medical Ethics

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study

  • David J. Pulford1Email author,
  • Philipp Harter2,
  • Anne Floquet3,
  • Catherine Barrett4,
  • Dong Hoon Suh5,
  • Michael Friedlander6,
  • José Angel Arranz7,
  • Kosei Hasegawa8,
  • Hiroomi Tada9, 22,
  • Peter Vuylsteke10,
  • Mansoor R. Mirza11,
  • Nicoletta Donadello12,
  • Giovanni Scambia13,
  • Toby Johnson1,
  • Charles Cox1,
  • John K. Chan14,
  • Martin Imhof15,
  • Thomas J. Herzog16,
  • Paula Calvert17,
  • Pauline Wimberger18,
  • Dominique Berton-Rigaud19,
  • Myong Cheol Lim20,
  • Gabriele Elser21,
  • Chun-Fang Xu1 and
  • Andreas du Bois2
BMC Medical EthicsBMC series – open, inclusive and trusted201617:63

https://doi.org/10.1186/s12910-016-0144-y

Received: 15 January 2016

Accepted: 7 October 2016

Published: 21 October 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
15 Jan 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
7 Oct 2016 Editorially accepted
21 Oct 2016 Article published 10.1186/s12910-016-0144-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
GlaxoSmithKline Medicines Research Centre
(2)
AGO Study group and Department of Gynecology & Gynecologic Oncology, Kliniken Essen Mitte (KEM)
(3)
GINECO and Medical Oncology, Institut Bergonié
(4)
GSK Stockley Park West
(5)
Department of Obstetrics & Gynecology, KGOG and Seoul National University Bundang Hospital
(6)
ANZGOG and The Prince of Wales Clinical School University of New South Wales
(7)
GEICO and Hospital General Universitario Gregorio Marañón
(8)
JGOG and Saitama Medical University International Medical Center
(9)
GlaxoSmithKline Research and Development
(10)
BGOG and Medical Oncology, Université Catholique de Louvain
(11)
NSGO and Rigshospitalet
(12)
MaNGO and Ospedale Filippo del Ponte
(13)
Department of Woman Health, MITO and Catholic University of the Sacred Heart
(14)
Palo Alto Medical Foundation
(15)
Karl Landsteiner Research Institute and Department of Obstetrics and Gynecology, General Public Teaching Hospital, Korneuburg
(16)
NYGOG and University of Cincinnati Cancer Institute
(17)
Cancer Trials Ireland
(18)
AGO Germany and Department of Gynecology and Obstetrics, TU Dresden, Carl-Gustav-Carus University
(19)
GINECO and ICO Centre René Gauducheau
(20)
KGOG, Gynecologic Cancer Branch and Center for Uterine Cancer, National Cancer Center
(21)
AGO Study Group
(22)
Immuno-Oncology Development, Incyte Corporation

Advertisement